Although DNA-damaging agents are known to induce the IFN response in vitro24,26, much less is known about methylation damage and its potential to drive IFN signaling in vivo, a critical gap in knowledge that is relevant to cancer susceptibility. The gene discussed is IFNA1; the disease is cancer.